SCHEMBL13738733

SCHEMBL13738733

CC(CO)Cn1cc(Br)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.46
OPRK1 P41145 1/20 0.43
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
ALDH1A1 P00352 4/20 0.39
JAK2 O60674 2/20 0.38
JAK1 P23458 2/20 0.38
TYK2 P29597 2/20 0.38
JAK3 P52333 2/20 0.38
ACHE P22303 2/20 0.37
HSD17B10 Q99714 2/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
LMNA P02545 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HTT P42858 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
F2 P00734 1/20 0.32
PLAU P00749 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16912027 0.81 ACHE (0.49) HPGDOPRK1KMT2AMAPTPKM
SCHEMBL18704887 0.80 JAK2 (0.39) OPRK1JAK2JAK1TYK2JAK3
SCHEMBL12460187 0.80 JAK2 (0.39) OPRK1KMT2AALDH1A1JAK2JAK1
SCHEMBL27868138 0.78 HPGD (0.40) HPGDOPRK1KMT2AMAPTPKM
SCHEMBL20962646 0.77 JAK2 (0.40) MAPTJAK2JAK1TYK2JAK3
SCHEMBL27696475 0.76 HPGD (0.47) HPGDOPRK1PKMALDH1A1ACHE
SCHEMBL659599 0.75 HPGD (0.46) HPGDOPRK1KMT2AMAPTPKM
SCHEMBL26971344 0.73 HPGD (0.46) HPGDOPRK1KMT2AMAPTPKM
SCHEMBL28518544 0.72 OPRK1 (0.44) HPGDOPRK1KMT2AMAPTPKM
SCHEMBL27133697 0.72 KMT2A (0.39) HPGDOPRK1KMT2AMAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020043080-A1 FUSED TRICYCLIC COMPOUNDS AND USES THEREOF IN MEDICINE SUNSHINE LAKE PHARMA CO., LTD. (CN) 2020-03-05 WO disclosed
EP-2702042-A1 NOVEL BICYCLIC NITROGEN CONTAINING HETEROARYL TGR5 RECEPTOR MODULATORS Bristol-Myers Squibb Company (US) 2014-03-05 EP disclosed
WO-2012149236-A1 NOVEL BICYCLIC NITROGEN CONTAINING HETEROARYL TGR5 RECEPTOR MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-11-01 WO disclosed